Octreotide inhibits myeloperoxidase activity in rat uterus

References

• Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179: 77–9.
   Google Scholar
• Reichlin S. Somatostatin. N Engl J Med 1983; 309: 1495501.
   Google Scholar
• Schudziarra V. Somatostatin-physiological and pathophysiological aspects. Scand J Gastroenterol 1983; 82: 69–84.
   Google Scholar
• Lamberts SWJ. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogues in the treatment of human pituitary tumors. Endocr Rev 1988; 9: 419–36.
   Google Scholar
• Holst N, Jacobsen MB, Haug E, Tanbo T, Abyholm T. Somatostatin in physiological concentrations inhibits basal and enhances luteinizing hormone-stimulated progesterone release from human granulosa-luteal cells. Hum Reprod 1995; 10: 1363–6.
   Google Scholar
• Andreani CL, Lazzarin N, Pierro E, Lanzone A, Mancuso S. Somatostatin action on rat ovarian steroidogenesis. Hum Reprod 1995; 10: 1968–73.
   Google Scholar
• Prelevic GM, Wurzbuger MI, Balint-Peric L, Nesic JS. Inhibitory effect of sandostatin on secretion of luteinizing hormone and ovarian steroids in polycystic ovary syndrome. Lancet 1990; 336: 900–3.
   Google Scholar
• Fulghesu AM, Lanzone A, Andreani CL, Pierro E, Caruso A, Mancuso S. Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease. Fertil Steril 1995; 64: 703–8.
   Google Scholar
• Mimuro T, Smith H, Iwashita M, Illingworth PJ. The somatostatin analogue, octreotide, modifies both steroidogenesis and IGFBP-1 secretion in human luteinizing granulosa cells. Hum Reprod 1998; 13: 150–3.
   Google Scholar
• Lanzone A, Fulghesu AM, Guido M, Cucinelli F, Caruso A, Mancuso S. Somatostatin treatment reduces the exaggerated response of adrenecorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome. Fertil Steril 1997; 67: 34–9.
   Google Scholar
• van der Meer M, de Boer JAM, Hompes PGA, Schoemaker J. Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome. Hum Reprod 1998; 13: 1465–9.
   Google Scholar
• Katagiri S, Moon YS, Yuen BH. A somatostatin analogue decreases embryonic loss following superovulation in rats by normalizing insulin-like growth factor-1 action in the uterus. Hum Reprod 1997; 12: 671–6.
   Google Scholar
• Suzuki K, Otta H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Annal Biochem 1983; 132: 345–52.
   Google Scholar
• Bieth J, Spiess B, Vermuth CG. The synthesis and analytical use of highly sensitive and convenient substrate of elastase. Biochem Med 1974; 11: 350–7.
   Google Scholar
• Bauer W, Briner V, Doepfner W, Haller R, Huguenin R, Marbach P et al. SMS 201–995 a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982; 31: 1133–40.
   Google Scholar
• Lamberts SWJ, Uitterlinden P, Verschoor L, van Dongen KJ, del Pozo E. Long-term treatment of acromegaly with the somatostatin analogue SMS 201–995. N Engl J Med 1985; 313: 1576–80.
   Google Scholar
• Kvols LK, Moertel CG, O’Connell MJ, Schult AJ, Rubin J, Hahn RG. Treatment of malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986; 315: 663–6.
   Google Scholar
• Morris RS, Carmina E, Vijod MA, Stanczyk FZ, Lobo RA. Alterations in the sensitivity of serum insulin-like growth factor 1 and insulin-like growth factor binding protein-3 to octreotide in polycystic ovary syndrome. Fertil Steril 1995; 63: 742–6.
   Google Scholar
• King A, Burrows T, Verma S, Hiby S, Loke YW. Human uterine lymphocytes. Hum Reprod Update 1998; 4: 480–5.
   Google Scholar
• Fetissof F, Arbeille B, Buchet C, Rigal J, Lansac J. Malignant mixed mesodermal tomor with endocrine cells of the corpus uteri. Ann Pathol 1987;7: 11–14.
   Google Scholar